Wei Duan

628 total citations
20 papers, 471 citations indexed

About

Wei Duan is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Wei Duan has authored 20 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Wei Duan's work include Drug Transport and Resistance Mechanisms (3 papers), Cervical Cancer and HPV Research (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Wei Duan is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cervical Cancer and HPV Research (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Wei Duan collaborates with scholars based in China, United States and Australia. Wei Duan's co-authors include Chun Guang Li, Yong Li, Yuan Ming Di, Linlin Wang, Shu‐Feng Zhou, Charlie Changli Xue, Xi-Yong Yu, Jingyuan Wen, Zhi-Wei Zhou and Lin Shu-guang and has published in prestigious journals such as Cancer Research, Nanoscale and Medicine.

In The Last Decade

Wei Duan

16 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Duan China 7 253 174 76 71 61 20 471
Henrike Bruckmueller Germany 16 241 1.0× 194 1.1× 109 1.4× 126 1.8× 42 0.7× 25 600
Dongli Sun China 15 126 0.5× 206 1.2× 54 0.7× 49 0.7× 28 0.5× 33 518
Luigi Candussio Italy 15 255 1.0× 231 1.3× 111 1.5× 57 0.8× 32 0.5× 42 664
Archie Thurston United States 12 124 0.5× 166 1.0× 47 0.6× 72 1.0× 30 0.5× 18 496
Peter Tobin Australia 8 191 0.8× 207 1.2× 34 0.4× 28 0.4× 55 0.9× 11 421
Jiake He China 12 138 0.5× 149 0.9× 50 0.7× 68 1.0× 28 0.5× 31 411
Xiaoping Chen China 14 244 1.0× 203 1.2× 30 0.4× 29 0.4× 61 1.0× 32 520
Paresh P. Chothe United States 14 299 1.2× 178 1.0× 139 1.8× 129 1.8× 45 0.7× 34 571
Marianne K. DeGorter Canada 11 148 0.6× 205 1.2× 87 1.1× 78 1.1× 165 2.7× 16 644
J.H.M. Schellens Netherlands 10 378 1.5× 141 0.8× 118 1.6× 86 1.2× 50 0.8× 15 528

Countries citing papers authored by Wei Duan

Since Specialization
Citations

This map shows the geographic impact of Wei Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Duan more than expected).

Fields of papers citing papers by Wei Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Duan. The network helps show where Wei Duan may publish in the future.

Co-authorship network of co-authors of Wei Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Duan. A scholar is included among the top collaborators of Wei Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Duan. Wei Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Pengfei, et al.. (2025). Clinical Characteristics and Risk Factors of Patients with Lung Cancer Complicated with Pulmonary Embolism: A Case Control Study. Clinical and Applied Thrombosis/Hemostasis. 31. 3005493406–3005493406.
4.
Chen, Sha, Ting Lv, Shan Shan, et al.. (2023). Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis. Journal of Digestive Diseases. 24(6-7). 419–426. 1 indexed citations
5.
Gao, Qinglei, Jing Wang, Qin Xu, et al.. (2023). Abstract CT079: Efficacy and safety of sintilimab (anti-PD-1 mAb) for advanced cervical cancer: Results from a Phase II trial. Cancer Research. 83(8_Supplement). CT079–CT079.
6.
7.
8.
He, Jie, et al.. (2021). [Application of double plasma molecular adsorption system in children with acute liver failure].. PubMed. 23(2). 180–185. 5 indexed citations
9.
Duan, Wei, et al.. (2020). Kikuchi's disease with hemophagocytic lymphohistiocytosis. Medicine. 99(51). e23500–e23500. 13 indexed citations
10.
Jiang, Yuqian, et al.. (2020). The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance. Nanoscale. 12(31). 16451–16461. 15 indexed citations
11.
Li, Yi, et al.. (2019). [Present status of diagnosis and treatment of hepatolenticular degeneration].. PubMed. 27(3). 161–165. 3 indexed citations
12.
Yang, Shuyu, Wei Duan, Weimin Kong, Li Zhu, & Yumei Wu. (2016). Study of clinical diagnosis of cervical glandular intraepithelial neoplasia.. PubMed. 37(4). 539–542. 1 indexed citations
13.
Li, Xiaoyan, et al.. (2016). Immunoglobulin G4-related acquired hemophilia: A case report. Experimental and Therapeutic Medicine. 12(6). 3988–3992. 6 indexed citations
14.
He, Yue, Tong Wang, Yan Wang, et al.. (2014). Clinical Value of Cold Knife Conization as Conservative Management in Patients With Microinvasive Cervical Squamous Cell Cancer (Stage IA1). International Journal of Gynecological Cancer. 24(7). 1306–1311. 8 indexed citations
15.
Li, Yan, et al.. (2013). Morphology Variation and Optical Properties of ZnO Nanostructures Grown Using Bio-Template. Journal of Nanoscience and Nanotechnology. 13(2). 1304–1308. 1 indexed citations
16.
Duan, Wei, et al.. (2011). Stability and Nonlinear Optical Properties of ZnO Nanoparticles. Journal of Nanoscience and Nanotechnology. 11(11). 9877–9882. 1 indexed citations
17.
Liu, Boyang, Wei Duan, Ming Zhao, et al.. (2009). Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-β-arabinofuranosylcytosine. European Journal of Medicinal Chemistry. 44(9). 3596–3600. 25 indexed citations
18.
Zhou, Shu‐Feng, Linlin Wang, Yuan Ming Di, et al.. (2008). Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development. Current Medicinal Chemistry. 15(20). 1981–2039. 273 indexed citations
19.
Yu, Xi-Yong, Lin Shu-guang, Zhi-Wei Zhou, et al.. (2007). Role of P-Glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia miltiorrhiza Bunge. Current Drug Metabolism. 8(4). 325–340. 61 indexed citations
20.
Tian, Quan, Jing Zhang, Sui Yung Chan, et al.. (2005). Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4. Current Drug Metabolism. 7(1). 105–118. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrike Bruckmueller Breakdown of academic impact, for papers by Dongli Sun Breakdown of academic impact, for papers by Luigi Candussio Breakdown of academic impact, for papers by Archie Thurston Breakdown of academic impact, for papers by Peter Tobin Breakdown of academic impact, for papers by Jiake He Breakdown of academic impact, for papers by Xiaoping Chen Breakdown of academic impact, for papers by Paresh P. Chothe Breakdown of academic impact, for papers by Marianne K. DeGorter Breakdown of academic impact, for papers by J.H.M. Schellens
Rankless by CCL
2026